Cargando…
Effects of ticagrelor in a mouse model of ischemic stroke
Ticagrelor is a direct acting and reversibly binding P2Y12 antagonist approved for the prevention of thromboembolic events. Its potential benefits in ischemic stroke have not been investigated sufficiently. Mice were subjected to 2 hours of transient middle cerebral artery occlusion (MCAO). Mice wer...
Autores principales: | Yamauchi, Keita, Imai, Takahiko, Shimazawa, Masamitsu, Iwama, Toru, Hara, Hideaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608945/ https://www.ncbi.nlm.nih.gov/pubmed/28935927 http://dx.doi.org/10.1038/s41598-017-12205-w |
Ejemplares similares
-
Diabetes Mellitus Aggravates Hemorrhagic Transformation after Ischemic Stroke via Mitochondrial Defects Leading to Endothelial Apoptosis
por: Mishiro, Keisuke, et al.
Publicado: (2014) -
Involvement of Mincle and Syk in the changes to innate immunity after ischemic stroke
por: Suzuki, Yukiya, et al.
Publicado: (2013) -
Intracellular Fe(2+) accumulation in endothelial cells and pericytes induces blood-brain barrier dysfunction in secondary brain injury after brain hemorrhage
por: Imai, Takahiko, et al.
Publicado: (2019) -
Ticagrelor Resistance in Cardiovascular Disease and Ischemic Stroke
por: He, Song, et al.
Publicado: (2023) -
Retinal Diseases Associated with Oxidative Stress and the Effects of a Free Radical Scavenger (Edaravone)
por: Masuda, Tomomi, et al.
Publicado: (2017)